Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody binding to TMEM132A, anticancer agent, and cancer test method

Antibody binding to TMEM132A, anticancer agent, and cancer test method

US Patent 11192956 · Granted Dec 7, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion protein suitable for dissolving fibrin clot, and pharmaceutical compositi2025
Fusion protein suitable for dissolving fibrin clot, and pharmaceutical compositi2025
Fusion protein suitable for dissolving fibrin clot, and pharmaceutical compositi2025
Vehicle drive device2023
Anti-TMEM-180 antibody, anticancer drug and cancer testing method2023
Anti-TMEM-180 antibody, anticancer drug and cancer testing method2023
Anti-TMEM-180 antibody, anticancer drug and cancer testing method2023
Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and can2022
Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and can2022
Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and can2022
Antibody beneficial for treatment of solid tumors, antibody-drug conjugate, and 2022
Antibody beneficial for treatment of solid tumors, antibody-drug conjugate, and 2022